CLINICAL_TRIALS
trial_result
· 2026-03-17
Clinical Trial Update: Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine [Phase 2]
Summary
Phase 2 dose-ranging study evaluating a 25-valent pneumococcal conjugate vaccine has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inventprise Inc. | Conditions: Pneumococcal Vaccines | Phase 2 | Status: COMPLETED | Results posted: 2026-03-17